Conmed Corp (N:CNMD)

Business Focus: Medical Equipment, Supplies & Distribution

Apr 02, 2024 04:05 pm ET
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, April 24, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Feb 27, 2024 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on February 26, 2024, payable on April 5, 2024, to all shareholders of record as of March 15, 2024.
Jan 31, 2024 04:05 pm ET
CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2023.
Jan 03, 2024 04:05 pm ET
CONMED Corporation to Announce Fourth Quarter 2023 Financial Results on January 31, 2024
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2023 after the market close on Wednesday, January 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Dec 21, 2023 04:05 pm ET
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan Healthcare Conference at 2:15 p.m. PT (5:15 p.m. ET) on Monday, January 8, 2024 in San Francisco, CA.
Dec 05, 2023 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on December 4, 2023, payable on January 5, 2024, to all shareholders of record as of December 18, 2023.
Nov 13, 2023 04:05 pm ET
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Piper Sandler Healthcare Conference at 9:00 a.m. ET on Tuesday, November 28, 2023.
Oct 31, 2023 04:05 pm ET
CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 14-15
CONMED Corporation (NYSE: CNMD) today announced that it will participate in fireside chats at the following two investor conferences in November:
Oct 25, 2023 04:05 pm ET
CONMED Corporation Announces Third Quarter 2023 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2023.
Oct 04, 2023 04:05 pm ET
CONMED Corporation to Announce Third Quarter 2023 Financial Results on October 25, 2023
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2023 after the market close on Wednesday, October 25, 2023. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Sep 05, 2023 04:05 pm ET
CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference
CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the CL King 21st Annual Best Ideas Conference at 10:15 a.m. ET on Monday, September 18, 2023.
Aug 24, 2023 04:05 pm ET
CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Wells Fargo Healthcare Conference at 2:15 p.m. ET on Thursday, September 7, 2023.
Aug 10, 2023 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2023, to all shareholders of record as of September 15, 2023. 
Jul 26, 2023 04:05 pm ET
CONMED Corporation Announces Second Quarter 2023 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2023.
Jul 05, 2023 04:05 pm ET
CONMED Corporation to Announce Second Quarter 2023 Financial Results on July 26, 2023
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2023 after the market close on Wednesday, July 26, 2023. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
May 25, 2023 04:05 pm ET
CONMED Corporation to Participate in a Fireside Chat at the Jefferies Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Jefferies Healthcare Conference at 10:00 a.m. ET on Thursday, June 8, 2023.
May 24, 2023 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 5, 2023, to all shareholders of record as of June 15, 2023.
Apr 26, 2023 04:05 pm ET
CONMED Corporation Announces First Quarter 2023 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2023.
Apr 04, 2023 04:05 pm ET
CONMED Corporation to Announce First Quarter 2023 Financial Results on April 26, 2023
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2023 after the market close on Wednesday, April 26, 2023. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Mar 22, 2023 04:05 pm ET
CONMED Corporation Announces Annual Meeting of Stockholders
CONMED Corporation (NYSE: CNMD) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 24, 2023, at 1:30 p.m. ET at its corporate headquarters at 11311 Concept Boulevard, Largo FL and through the internet virtually. Shareholders of record at the close of business on March 28, 2023 shall be entitled to vote at the 2023 Annual Meeting.
Mar 14, 2023 04:05 pm ET
CONMED Corporation to Participate in a Virtual Fireside Chat at the KeyBanc Life Sciences and MedTech Investor Forum
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences and MedTech Investor Forum at 9:00 a.m. ET on Wednesday, March 22, 2023.
Feb 27, 2023 04:05 pm ET
Feb 02, 2023 04:05 pm ET
CONMED Corporation Announces Fourth Quarter and Full-Year 2022 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2022.
Jan 09, 2023 04:05 pm ET
CONMED Corporation to Announce Fourth Quarter 2022 Financial Results on February 2, 2023
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2022 after the market close on Thursday, February 2, 2023. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Dec 05, 2022 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 5, 2023, to all shareholders of record as of December 16, 2022.
Nov 22, 2022 04:05 pm ET
CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 34th Annual Piper Sander Healthcare Conference at 3:30 p.m. ET on Wednesday, November 30, 2022.
Nov 15, 2022 07:00 am ET
CONMED Corporation Withdraws 2022 Financial Outlook due to Temporary Impact from Software Implementation; Provides 2023 Financial Outlook
CONMED Corporation (NYSE: CNMD) today announced that due to a temporary disruption resulting from the implementation of new warehouse management software, the Company is withdrawing its previously issued full-year 2022 financial outlook.
Nov 07, 2022 04:05 pm ET
CONMED Corporation to Participate in a Fireside Chat at the Stifel 2022 Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Stifel 2022 Healthcare Conference at 1:15 p.m. ET on Tuesday, November 15, 2022.
Oct 26, 2022 04:05 pm ET
CONMED Corporation Announces Third Quarter 2022 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2022.
Oct 10, 2022 04:05 pm ET
CONMED Corporation to Announce Third Quarter 2022 Financial Results on October 26, 2022
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2022 after the market close on Wednesday, October 26, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Sep 06, 2022 04:05 pm ET
CONMED Corporation to Participate in a Fireside Chat at the Morgan Stanley Global Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference at 5:15 p.m. ET on Tuesday, September 13, 2022.
Aug 11, 2022 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2022 to all shareholders of record as of September 15, 2022.
Aug 09, 2022 04:05 pm ET
CONMED Completes Acquisition of Biorez, Inc.
CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held Biorez, Inc.
Aug 01, 2022 04:05 pm ET
CONMED Announces Definitive Agreement to Acquire Biorez, Inc.
CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately held Biorez, Inc. (Biorez), on a cash-free, debt-free basis, for cash consideration of $85 million at closing, subject to adjustment, and up to an additional $165 million in growth-based earnout payments over a four-year period. The transaction is expected to be financed through the company's existing credit facility. The transaction is expected to close in early August 2022.
Jul 27, 2022 04:05 pm ET
CONMED Corporation Announces Second Quarter 2022 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2022.
Jul 05, 2022 04:05 pm ET
CONMED Corporation to Announce Second Quarter 2022 Financial Results on July 27, 2022
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2022 after the market close on Wednesday, July 27, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Jun 13, 2022 04:05 pm ET
CONMED Completes Acquisition of In2Bones Global, Inc.
CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held In2Bones Global Inc.
Jun 01, 2022 11:22 pm ET
CONMED Corporation Announces Pricing of Upsized $700 Million Offering of Convertible Senior Notes
CONMED Corporation (NYSE: CNMD) today announced the pricing of $700 million aggregate principal amount of 2.25% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering of the notes, CONMED has granted the initial purchasers an option to purchase, for settlement within a 13-day period beginning on, and including, the first day on which the notes are issued, up to an additional $100 million aggregate principal amount of the notes. The
May 31, 2022 04:05 pm ET
CONMED Corporation Announces Private Offering of $600 Million of Convertible Senior Notes
CONMED Corporation (NYSE: CNMD) today announced that it intends to offer, subject to market conditions and other factors, $600 million aggregate principal amount of its convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering of the notes, CONMED expects to grant the initial purchasers an option to purchase, for settlement within a 13-day period beginning on, and including, the first day on which the notes are issued, up to an additi
May 24, 2022 05:20 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 5, 2022 to all shareholders of record as of June 15, 2022.
May 04, 2022 04:05 pm ET
CONMED Announces Definitive Agreement to Acquire In2Bones Global, Inc.
Headquartered in Memphis, Tennessee, In2Bones is a global developer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. The company’s comprehensive product portfolio includes implants, fracture systems, biologics, and related hardware.
May 04, 2022 04:05 pm ET
CONMED Corporation Announces First Quarter 2022 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2022.
Apr 19, 2022 04:05 pm ET
CONMED Corporation Reschedules First Quarter 2022 Financial Results Conference Call to May 4, 2022
CONMED Corporation (NYSE: CNMD) today announced that it will reschedule the reporting of its first quarter 2022 financial results due to a corporate conflict. The release of these financial results, which was previously scheduled for Wednesday, April 27, 2022, will now take place on Wednesday, May 4, 2022, after the market close. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Apr 01, 2022 04:05 am ET
CONMED Corporation to Announce First Quarter 2022 Financial Results on April 27, 2022
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2022 after the market close on Wednesday, April 27, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Mar 23, 2022 04:05 pm ET
CONMED Corporation Announces Annual Meeting of Stockholders
CONMED Corporation (NYSE: CNMD) today announced that its Annual Meeting of Stockholders will be held as a virtual meeting on Wednesday, May 25, 2022, at 1:30 p.m. ET. Shareholders of record at the close of business on April 5, 2022 shall be entitled to vote at the 2022 Annual Meeting.
Feb 28, 2022 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2022 to all shareholders of record as of March 15, 2022.
Jan 26, 2022 04:05 pm ET
CONMED Corporation Announces Fourth Quarter and Full-Year 2021 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2021.
Jan 03, 2022 04:05 pm ET
CONMED Corporation to Announce Fourth Quarter 2021 Financial Results on January 26, 2022
CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the fourth quarter 2021 after the market close on Wednesday, January 26, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Jan 03, 2022 04:05 pm ET
CONMED Corporation to Participate in the 40th Annual JP Morgan Virtual Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President & Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 40th Annual J.P. Morgan Virtual Healthcare Conference at 9:00 a.m. ET on Monday, January 10, 2022.
Nov 29, 2021 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 5, 2022 to all shareholders of record as of December 15, 2021.
Nov 18, 2021 04:05 pm ET
CONMED Corporation to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference.
Nov 09, 2021 06:01 pm ET
CONMED Corporation to Participate at the Stifel 2021 Virtual Healthcare Conference on November 16, 2021
CONMED Corporation (NYSE: CNMD) today announced Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a presentation at the Stifel 2021 Virtual Healthcare Conference at 2:40 p.m. ET on Tuesday, November 16, 2021.
Nov 09, 2021 04:15 pm ET
CONMED Corporation to Participate at the Stifel 2021 Virtual Healthcare Conference on November 16, 2021
A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.conmed.com.
Oct 27, 2021 04:05 pm ET
CONMED Corporation Announces Third Quarter Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2021.
Oct 04, 2021 04:05 pm ET
CONMED Corporation to Announce Third Quarter 2021 Financial Results on October 27, 2021
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2021 after the market close on October 27, 2021. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Sep 07, 2021 04:05 pm ET
CONMED Corporation to Participate in a Virtual Fireside Chat at the Morgan Stanley Global Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the 19th Annual Morgan Stanley Global Healthcare Conference at 5:00 p.m. ET on Tuesday, September 14, 2021.
Aug 12, 2021 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2021 to all shareholders of record as of September 15, 2021.
Jul 28, 2021 04:05 pm ET
CONMED Corporation Announces Second Quarter Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2021.
Jul 01, 2021 04:05 pm ET
CONMED Corporation to Announce Second Quarter 2021 Financial Results on July 28, 2021
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2021 after the market close on Wednesday, July 28, 2021. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
May 19, 2021 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 6, 2021 to all shareholders of record as of June 15, 2021.
Apr 28, 2021 04:05 pm ET
CONMED Corporation Announces First Quarter Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2021.
Apr 01, 2021 04:05 pm ET
CONMED Corporation to Announce First Quarter 2021 Financial Results on April 28, 2021
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2021 after the market close on Wednesday, April 28, 2021. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Mar 23, 2021 04:05 pm ET
CONMED Corporation Announces Annual Meeting of Stockholders
CONMED Corporation (NYSE: CNMD) today announced that its Annual Meeting of Stockholders will be held as a virtual meeting on Wednesday, May 19, 2021, at 1:30 p.m. ET. Shareholders of record at the close of business on March 29, 2021 shall be entitled to vote at the 2021 Annual Meeting.
Mar 15, 2021 04:05 pm ET
CONMED Corporation to Participate in a Virtual Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 11:30 a.m. ET on Tuesday, March 23, 2021.
Feb 23, 2021 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2021 to all shareholders of record as of March 15, 2021.
Feb 16, 2021 04:05 pm ET
CONMED Corporation to Participate in a Virtual Fireside Chat at the SVB Leerink Global Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference at 9:20 a.m. ET on Thursday, February 25, 2021.
Jan 27, 2021 04:05 pm ET
CONMED Corporation Announces Fourth Quarter and Full-Year 2020 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter ended December 31, 2020.
Jan 13, 2021 04:05 pm ET
CONMED Corporation to Announce Fourth Quarter and Full-Year 2020 Financial Results on January 27, 2021
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter and full year 2020 after the market close on Wednesday, January 27, 2021. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Jan 05, 2021 04:05 pm ET
CONMED Corporation to Present at the J.P. Morgan Virtual Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President & Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference at 10:00 a.m. ET on Monday, January 11, 2021.
Nov 23, 2020 04:05 pm ET
CONMED Corporation to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President, Chief Executive Officer and Chair of the Board, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference.
Nov 13, 2020 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 5, 2021 to all shareholders of record as of December 15, 2020.
Nov 10, 2020 04:05 pm ET
CONMED Corporation Announces Presentation Time Change at the Jefferies Virtual London Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that its presentation time at the Jefferies Virtual London Healthcare Conference has been changed to 11:25 a.m. ET on Wednesday, November 18, 2020. Representing the Company will be Todd W. Garner, Executive Vice President and Chief Financial Officer.
Nov 09, 2020 04:05 pm ET
CONMED Corporation to Present at the Jefferies Virtual London Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Jefferies Virtual London Healthcare Conference at 12:25 p.m. ET on Wednesday, November 18, 2020.
Nov 05, 2020 04:05 pm ET
CONMED Corporation to Present at the Stifel Virtual Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President, Chief Executive Officer and Chair of the Board, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Stifel Virtual Healthcare Conference at 10:00 a.m. ET on Monday, November 16, 2020.
Oct 28, 2020 04:05 pm ET
CONMED Corporation Announces Third Quarter 2020 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2020.
Oct 01, 2020 04:05 pm ET
CONMED Corporation to Announce Third Quarter 2020 Financial Results on October 28, 2020
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter of 2020 after the market close on Wednesday, October 28, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Sep 03, 2020 04:05 pm ET
CONMED Corporation to Present at the Morgan Stanley Global Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President, Chief Executive Officer and Chair of the Board, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference at 3:30 p.m. ET on Wednesday, September 16, 2020.
Aug 13, 2020 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2020 to all shareholders of record as of September 15, 2020.
Jul 29, 2020 04:05 pm ET
CONMED Corporation Announces Second Quarter 2020 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2020.
Jul 01, 2020 04:05 pm ET
CONMED Corporation to Announce Second Quarter 2020 Financial Results on July 29, 2020
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter of 2020 after the market close on Wednesday, July 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
May 21, 2020 04:05 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 6, 2020 to all shareholders of record as of June 15, 2020.
May 11, 2020 07:00 am ET
CONMED Corporation Announces That 2020 Annual Meeting of Shareholders Will Be Virtual-Only Meeting Due to COVID-19
CONMED Corporation (NYSE: CNMD) today announced that its 2020 Annual Meeting of Shareholders, scheduled for May 21, 2020, at 1:30 p.m. ET, will be hosted as a virtual-only meeting due to public health concerns and social-distancing restrictions imposed by governmental authorities with respect to non-essential gatherings arising from the COVID-19 pandemic.
May 04, 2020 04:05 pm ET
CONMED Corporation to Present at the BofA Securities Virtual Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the BofA Securities Virtual Healthcare Conference at 9:40 a.m. ET on Tuesday, May 12, 2020.
Apr 29, 2020 04:05 pm ET
CONMED Corporation Announces First Quarter 2020 Financial Results
CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2020.
Apr 20, 2020 07:00 am ET
CONMED Corporation Announces Amendment to its Existing Credit Agreement
CONMED Corporation (NYSE: CNMD) today announced an amendment to its existing credit agreement, including adjustments to, and suspension of, certain debt covenant thresholds. The terms of the amended agreement are temporary in nature and were granted to provide the Company with financial assurance and flexibility as it navigates the COVID-19 pandemic.
Apr 07, 2020 04:05 pm ET
CONMED Corporation to Announce First Quarter 2020 Financial Results on April 29, 2020
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter of 2020 after the market close on Wednesday, April 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Mar 31, 2020 04:05 pm ET
CONMED Corporation Announces Virtual 2020 Annual Meeting of Shareholders
CONMED Corporation (NYSE: CNMD) today announced that the 2020 Annual Meeting of Shareholders will be held on May 21, 2020 at 1:30 p.m. ET. Shareholders as of the close of business on the record date, April 3, 2020, will be eligible to attend, vote at, and participate in the Annual Meeting.
Mar 16, 2020 07:00 am ET
CONMED Corporation Announces Changes to Board Leadership
CONMED Corporation (NYSE: CNMD) today announced that Mark E. Tryniski, Chair of the Board, has notified the Company that he will not stand for reappointment to the Chair position in May 2020, although he will stand for reelection as a director. The Board has appointed Curt R. Hartman to succeed Mr. Tryniski and serve as Chair, in addition to his role as Chief Executive Officer, effective immediately following the 2020 Annual Shareholder Meeting.
Mar 10, 2020 07:00 am ET
CONMED Corporation Provides Updated First Quarter Revenue Expectations to Reflect Anticipated Impact of COVID-19
CONMED Corporation (NYSE: CNMD) today announced updated revenue expectations for the first quarter of 2020 to reflect the anticipated impact of the COVID-19 (Coronavirus) outbreak on its global business.
Feb 26, 2020 04:05 pm ET
CONMED Corporation to Present at the Barclays Global Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Barclays Global Healthcare Conference at 10:15 a.m. ET on Tuesday, March 10, 2020 in Miami Beach, FL.
Feb 25, 2020 09:00 am ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 6, 2020 to all shareholders of record as of March 16, 2020.
Feb 20, 2020 08:00 am ET
Beta Bionics Appoints Martha Aronson and Sean Carney to Its Board as Independent Directors
Beta Bionics, Inc. — a medical technology company developing and aiming to commercialize the world’s first fully automated bionic pancreas system called the iLet® today announced that Martha G. Aronson and Sean D. Carney have been appointed to the...
Feb 12, 2020 04:05 pm ET
CONMED Corporation to Present at the SVB Leerink Global Healthcare Conference
CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 10:30 a.m. ET on Wednesday, February 26, 2020 in New York, NY.
Jan 29, 2020 04:03 pm ET
CONMED Corporation to Transfer Listing of Common Stock to the New York Stock Exchange
CONMED Corporation (NASDAQ: CNMD) today announced that it is transferring the listing of its common stock to the New York Stock Exchange (NYSE) from the NASDAQ Global Market.
Jan 29, 2020 04:01 pm ET
CONMED Corporation Announces Fourth Quarter and Full-Year 2019 Financial Results
CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2019.
Jan 06, 2020 04:01 pm ET
CONMED Corporation to Announce Fourth Quarter and Full-Year 2019 Financial Results on January 29, 2020
CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the fourth quarter and full year 2019 after the market close on Wednesday, January 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Jan 02, 2020 04:01 pm ET
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PT on Monday, January 13, 2020 in San Francisco, CA.
Nov 21, 2019 09:00 am ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NASDAQ: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 7, 2020 to all shareholders of record as of December 13, 2019.
Nov 11, 2019 04:01 pm ET
CONMED Corporation to Present at the Jefferies London Healthcare Conference
CONMED Corporation (NASDAQ: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Jefferies London Healthcare Conference at 9:20 a.m. GMT (4:20 a.m. ET) on Wednesday, November 20, 2019 in London, UK.
Oct 30, 2019 04:01 pm ET
CONMED Corporation Announces Third Quarter 2019 Financial Results
CONMED Corporation (Nasdaq: CNMD) today announced financial results for the third quarter of 2019.
Oct 07, 2019 04:01 pm ET
CONMED Corporation to Announce Third Quarter 2019 Financial Results on October 30, 2019
CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the third quarter of 2019 after the market close on Wednesday, October 30, 2019. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Sep 23, 2019 08:00 am ET
CONMED Corporation Adds LaVerne Council and Barbara Schwarzentraub to its Board of Directors
CONMED Corporation (NASDAQ: CNMD) announced today that LaVerne Council and Barbara Schwarzentraub are joining its Board of Directors. Ms. Schwarzentraub will join the Board effective immediately, with Ms. Council joining the Board effective as of December 1, 2019.
Aug 26, 2019 04:01 pm ET
CONMED Corporation to Present at the Morgan Stanley Global Healthcare Conference
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Morgan Stanley 17th Annual Global Healthcare Conference at 1:30 p.m. ET on Tuesday, September 10, 2019 in New York, NY.
Aug 02, 2019 09:00 am ET
Jul 31, 2019 04:01 pm ET
CONMED Corporation Announces Second Quarter 2019 Financial Results
CONMED Corporation (Nasdaq: CNMD) today announced financial results for the second quarter of 2019.
Jul 01, 2019 04:01 pm ET
CONMED Corporation to Announce Second Quarter 2019 Financial Results on July 31, 2019
CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the second quarter of 2019 after the market close on Wednesday, July 31, 2019. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Jun 18, 2019 08:00 am ET
Dirk Kuyper to Step Down from CONMED Corporation Board of Directors Effective August 1, 2019
CONMED Corporation (NASDAQ: CNMD) today announced that independent director, Dirk M. Kuyper, has submitted a notice of resignation, which will take effect on August 1, 2019.
May 22, 2019 09:00 am ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NASDAQ: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 5, 2019 to all shareholders of record as of June 14, 2019.
May 02, 2019 04:01 pm ET
CONMED Corporation to Present at the Bank of America Merrill Lynch Healthcare Conference
A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.conmed.com and will be available for replay following the event.
Apr 24, 2019 04:01 pm ET
CONMED Corporation Announces First Quarter 2019 Financial Results
CONMED Corporation (Nasdaq: CNMD) today announced financial results for the first quarter of 2019.
Apr 12, 2019 09:00 am ET
CONMED Corporation Announces Amended Start Time for Annual Meeting of Shareholders
CONMED Corporation (NASDAQ: CNMD) today announced an amended start time for its Annual Meeting of Shareholders. The meeting is now scheduled to begin at 1:30 p.m. ET.
Apr 08, 2019 08:25 am ET
Detailed Research: Economic Perspectives on MannKind, Sonic Automotive, Five Prime Therapeutics, CONMED, Cohu, and FTI Consulting — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of MannKind Corporation (NASDAQ:MNKD), Sonic Automotive, Inc. (NYSE:SAH),...
Apr 02, 2019 04:01 pm ET
CONMED Corporation to Announce First Quarter 2019 Financial Results on April 24, 2019
CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the first quarter of 2019 after the market close on Wednesday, April 24, 2019. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Mar 12, 2019 04:01 pm ET
CONMED Corporation Announces Annual Meeting of Shareholders
CONMED Corporation (NASDAQ:CNMD) today announced that its Annual Meeting of Shareholders will be held at the Company’s corporate offices, 525 French Road, Utica, NY on Wednesday, May 22, 2019, at 3:30 p.m. ET. Shareholders of record at the close of business on April 5, 2019 shall be entitled to vote at the 2019 Annual Meeting.
Feb 26, 2019 08:00 am ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NASDAQ:CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2019 to all shareholders of record as of March 15, 2019.
Feb 14, 2019 04:01 pm ET
CONMED Corporation to Present at the SVB Leerink Global Healthcare Conference
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 8th Annual SVB Leerink Global Healthcare Conference at 10:30 a.m. ET on Thursday, February 28, 2019 in New York, NY.
Feb 11, 2019 04:01 pm ET
CONMED Completes Acquisition of Buffalo Filter LLC
CONMED Corporation (NASDAQ: CNMD) today announced that it has completed its previously announced acquisition of privately-held Buffalo Filter LLC (Buffalo Filter) from Filtration Group.
Jan 25, 2019 07:45 am ET
Analysis: Positioning to Benefit within Neurocrine Biosciences, CONMED, TripAdvisor, Ryder System, Nordstrom, and Express — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Neurocrine Biosciences, Inc. (NASDAQ:NBIX), CONMED Corporation...
Jan 24, 2019 06:26 pm ET
CONMED Corporation Announces Pricing of $300 Million Offering of Convertible Senior Notes
CONMED Corporation (NASDAQ: CNMD) today announced the pricing of $300.0 million aggregate principal amount of 2.625% convertible senior notes due 2024 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering of the notes, CONMED has granted the initial purchasers an option to purchase, during a 13-day period beginning on, and including, the first day on which the notes are issued, up to an additional $45.0 million aggr
Jan 23, 2019 04:01 pm ET
CONMED Corporation Announces Private Offering of $275 Million of Convertible Senior Notes
CONMED Corporation (NASDAQ: CNMD) today announced that it intends to offer, subject to market conditions and other factors, $275 million aggregate principal amount of its convertible senior notes due 2024 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the offering of the notes, CONMED expects to grant the initial purchasers an option to purchase, during a 13-day period beginning on, and including, the first day on which t
Jan 22, 2019 04:01 pm ET
CONMED Corporation Announces Fourth Quarter and Full-Year 2018 Financial Results
CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2018.
Jan 08, 2019 04:01 pm ET
CONMED Corporation to Announce Fourth Quarter and Fiscal Year 2018 Financial Results on January 22, 2019
CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the fourth quarter and fiscal year 2018 after the market close on Tuesday, January 22, 2019. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Dec 20, 2018 04:01 pm ET
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PT on Wednesday, January 9, 2019 in San Francisco, CA.
Dec 13, 2018 04:01 pm ET
CONMED Announces Definitive Agreement to Acquire Buffalo Filter LLC
CONMED Corporation (NASDAQ:CNMD) today announced a definitive agreement to acquire privately-held Buffalo Filter LLC (Buffalo Filter) for $365 million on a cash-free, debt-free basis. The transaction is expected to be financed through a combination of new convertible notes and an expanded and amended credit facility. The transaction is subject to customary closing conditions, including receipt of U.S. regulatory approval, and is expected to close in the first quarter of 2019.
Nov 12, 2018 09:00 am ET
Consolidated Research: 2018 Summary Expectations for Murphy Oil, REGENXBIO, CRA International,Inc, Carriage Services, CONMED, and BioDelivery Sciences International — Fundamental Analysis, Key Perform
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Murphy Oil Corporation (NYSE:MUR), REGENXBIO Inc. (NASDAQ:RGNX), CRA...
Nov 08, 2018 04:01 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NASDAQ: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 7, 2019 to all shareholders of record as of December 14, 2018.
Nov 05, 2018 04:01 pm ET
CONMED Corporation to Present at the Jefferies London Healthcare Conference
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Jefferies London Healthcare Conference at 8:40 a.m. GMT (3:40 a.m. ET) on Wednesday, November 14, 2018 in London, UK.
Nov 01, 2018 04:01 pm ET
CONMED Corporation Announces Third Quarter 2018 Financial Results
CONMED Corporation (Nasdaq: CNMD) today announced financial results for the third quarter ended September 30, 2018.
Oct 18, 2018 04:01 pm ET
CONMED Corporation to Announce Third Quarter 2018 Financial Results on November 1, 2018
CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the third quarter of fiscal year 2018 after the market close on Thursday, November 1, 2018. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Oct 12, 2018 08:45 am ET
Recent Analysis Shows Carriage Services, Century Communities, Enable Midstream Partners, LP, MCBC, CONMED, and Chatham Lodging Trust (REIT) Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Carriage Services, Inc. (NYSE:CSV), Century Communities, Inc....
Aug 28, 2018 04:01 pm ET
CONMED Corporation to Present at the Morgan Stanley Global Healthcare Conference
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Morgan Stanley Global Healthcare Conference at 9:20 a.m. ET on Wednesday, September 12, 2018 in New York, NY.
Aug 14, 2018 04:01 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NASDAQ: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 8, 2018 to all shareholders of record as of September 14, 2018.
Aug 07, 2018 08:00 am ET
New Research: Key Drivers of Growth for Spire, CONMED, Natural Grocers by Vitamin Cottage, Immersion, Cross Country Healthcare, and PS Business Parks — Factors of Influence, Major Initiatives and Sust
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Spire Inc. (NYSE:SR), CONMED Corporation (NASDAQ:CNMD), Natural Grocers by...
Aug 01, 2018 04:01 pm ET
CONMED Corporation Announces Second Quarter 2018 Financial Results
CONMED Corporation (Nasdaq: CNMD) today announced financial results for the second quarter ended June 30, 2018.
Jun 25, 2018 04:01 pm ET
CONMED Corporation to Announce Second Quarter 2018 Financial Results on August 1, 2018
CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the second quarter of fiscal year 2018 after the market close on Wednesday, August 1, 2018. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
May 24, 2018 04:01 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NASDAQ:CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 5, 2018 to all shareholders of record as of June 15, 2018.
May 02, 2018 07:40 am ET
Market Trends Toward New Normal in Cohen & Steers, Achaogen, Ares Commercial Real Estate, CONMED, Marcus, and First Defiance Financial — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, May 02, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cohen & Steers Inc (NYSE:CNS), Achaogen,...
Apr 25, 2018 04:01 pm ET
CONMED Corporation Announces First Quarter 2018 Financial Results
CONMED Corporation (Nasdaq: CNMD) today announced financial results for the first quarter ended March 31, 2018.
Apr 05, 2018 04:01 pm ET
CONMED Corporation to Present at Two Investor Conferences in May
CONMED Corporation (NASDAQ:CNMD) today announced that it will present at the following two investor conferences in May.
Mar 22, 2018 04:01 pm ET
CONMED Corporation to Announce First Quarter 2018 Financial Results on April 25, 2018
CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the first quarter of fiscal year 2018 after the market close on Wednesday, April 25, 2018. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Mar 20, 2018 07:40 am ET
Analysis: Positioning to Benefit within AnaptysBio, MoSys, CONMED, Franklin Financial Network, Hersha Hospitality Trust, and Inovalon — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, March 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AnaptysBio, Inc. (NASDAQ:ANAB), MoSys, Inc. (NASDAQ:MOSY),...
Mar 12, 2018 08:00 am ET
CONMED Corporation Announces Annual Meeting of Shareholders
CONMED Corporation (NASDAQ:CNMD) today announced that its Annual Meeting of Shareholders will be held at the Company’s corporate offices, 525 French Road, Utica, NY on Wednesday, May 23, 2018, at 2:00 p.m. ET. Shareholders of record at the close of business on April 5, 2018 shall be entitled to vote at the 2018 Annual Meeting.
Feb 28, 2018 04:01 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NASDAQ:CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2018 to all shareholders of record as of March 15, 2018.
Feb 15, 2018 08:00 am ET
CONMED Corporation to Present at the Canaccord Genuity Musculoskeletal Conference
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Canaccord Genuity Musculoskeletal Conference at 10:30 a.m. CT on Tuesday, March 6, 2018 in New Orleans, LA.
Feb 05, 2018 08:00 am ET
CONMED Corporation to Present at the Leerink Partners 7th Annual Global Healthcare Conference
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Leerink Partners 7th Annual Global Healthcare Conference at 9:00 a.m. ET on Wednesday, February 14, 2018 in New York, New York.
Jan 31, 2018 04:01 pm ET
CONMED Corporation Announces Fourth Quarter and Fiscal Year 2017 Financial Results
CONMED Corporation (Nasdaq:CNMD) today announced financial results for the fourth quarter and fiscal year ended December 31, 2017.
Jan 31, 2018 10:00 am ET
CONMED Corporation to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / January 31, 2018 / CONMED Corporation (NASDAQ: CNMD) will be discussing their earnings results in their Q4 Earnings Call to be held on January 31, 2018 at 4:30 PM Eastern Time.
Jan 18, 2018 08:01 am ET
Factors of Influence in 2018, Key Indicators and Opportunity within United Therapeutics, LTC Properties, WageWorks, Clearwater Paper, United Insurance, and CONMED — New Research Emphasizes Economic Gr
NEW YORK, Jan. 18, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of United Therapeutics Corporation (NASDAQ:UTHR), LTC Properties,...
Jan 17, 2018 04:01 pm ET
CONMED Corporation to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on January 31, 2018
CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the fourth quarter and fiscal year 2017 after the market close on Wednesday, January 31, 2018. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Jan 02, 2018 04:01 pm ET
CONMED Corporation Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer
CONMED Corporation (NASDAQ:CNMD) today announced that it has appointed Todd W. Garner as Executive Vice President and Chief Financial Officer, effective immediately.
Dec 19, 2017 04:01 pm ET
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Luke A. Pomilio, Chief Financial Officer, will present at the 36th Annual J.P. Morgan Healthcare Conference at 4:00 p.m. PT on Wednesday, January 10, 2018 in San Francisco, CA.
Nov 27, 2017 04:01 pm ET
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (NASDAQ: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 5, 2018 to all shareholders of record as of December 15, 2017.
Nov 02, 2017 04:01 pm ET
CONMED Corporation Announces Retirement of Chief Financial Officer
CONMED Corporation (NASDAQ: CNMD) today announced that Luke A. Pomilio, Executive Vice President, Finance and Chief Financial Officer, has decided to retire after over two decades of service with the Company.
Nov 02, 2017 04:00 pm ET
CONMED Corporation Announces Third Quarter 2017 Financial Results
CONMED Corporation (Nasdaq:CNMD) today announced financial results for the third quarter ended September 30, 2017.
Oct 10, 2017 04:01 pm ET
CONMED Corporation to Announce Third Quarter 2017 Financial Results on November 2, 2017
CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the third quarter of fiscal year 2017 after the market close on Thursday, November 2, 2017. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
Jul 05, 2017 08:50 am ET
MedShape Sells ExoShape® ACL Product Line to CONMED Corporation
ATLANTA, July 5, 2017 /PRNewswire/ -- MedShape, Inc., the industry leader in orthopaedic devices using advanced functional materials, announced today that it has reached a definitive agreement with CONMED Corporation (Nasdaq: CNMD) for CONMED to acquire the ExoShape® ACL Fixation System. The acquisition, which closed July 3, 2017, includes both the ExoShape FEMORAL and TIBIAL Soft Tissue Fasteners, used to fixate soft tissue grafts in anterior cruciate ligament (ACL) reconstruction surgery.
Apr 13, 2017 01:02 pm ET
Jury Awards $10 Million In Punitive Damages Against SurgiQuest, A Subsidiary Of CONMED Corporation For False Advertising In Dispute With Lexion Medical
WILMINGTON, Del., April 13, 2017 /PRNewswire/ -- Lexion Medical, LLC of St. Paul, Minnesota announced today that a jury in the United States District Court for the District of Delaware found SurgiQuest, Inc. liable for false advertising.  SurgiQuest, Inc. is a subsidiary of CONMED Corporation (NASDAQ:CNMD).  The trial lasted 7 days before the Honorable Gregory M. Sleet, United States District Court Judge.  The case had been pending since 2014.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.